MGC Diagnostics’ Post

Calling All MGC Diagnostics Users! Share Your Testing Tips & Ask Us Anything!** We're always looking for ways to improve your experience with MGC Diagnostics products. Do you have any testing tips or tricks you'd like to share with the community? Maybe you have a question about a specific MGC Diagnostics product and can't find the answer? Let us know in the comments below! We'll be featuring some of the best tips and answering your questions throughout the week. #pulmonaryfunctiontesting #diagnostics #respiratorycare #community #CPET #SportsMedicine

The countdown begins! Are you attending World CB & CDx in London next week? Swing by our booth to discuss the latest companion diagnostics (CDx) innovations. Feel free to message us on LinkedIn to schedule a meeting or learn more. #cdx #companiondiagnostics #personalizedmedicine #worldcdx

DCRI's Jennifer Rymer and Schuyler Jones, along with former DCRI member Sunil Rao, joined their colleagues at #ACC24 this morning for a deep dive into the ACS toolbox, where they examined guidelines, proven and potential therapies, and opportunities to tailor approaches to each patient's unique characteristics and needs. Jones took the opportunity to reinforce GDMT adherence after ACS and noted 30% of patients still don't receive the Big 5 (aspirin, beta blockers, ACE inhibitors, statins, P2Y12 inhibitors). #clinicaltrials #clinicalresearch #hearthealth #heartdisease

2023 is about to come to a close so we want to take some time to look back on all the updates, partnerships, and enhancements that QSM Diagnostics celebrated throughout the year. https://hubs.ly/Q02dSLHK0 #pettech #petdiagnostics #qsmdiagnostics

🔍 Explore the latest advancements in cardiac safety assessments with Clario's upcoming webinar. Discover how FIH trials offer unique opportunities to identify and manage safety signals in new drug development. Learn about the advantages of utilizing EPQT to extract insights from small FIH trials, including its ability to assess the risk of QT interval prolongation. Gain insights into the development and capabilities of an AI-powered data quality tool, designed to enhance data assessment. Plus, engage directly with the experts during the live Q&A session. 🔗 REGISTER HERE: https://buff.ly/3UQ4HPZ Vickas Patel Alain GAY Jean-Philippe Couderc #DrugDevelopment #ClinicalResearch #ClinicalData #FirstInHuman #CardiacSafety

excellent overview of a truly dynamic field. It's great being part of it.

*Time change: Tuesday 9th Jan, 4 PM PST* We’re excited to present at the upcoming J.P. Morgan 42nd Annual Healthcare Conference taking place in San Francisco next week. Emanuele Ostuni will describe our novel #alpha #radioligandtherapy based on the ideal isotope, #Pb212, and its associated manufacturing approach to transform patient care. We look forward to a healthy conversation on the key drivers of efficacy in #radiopharmaceuticals, and on the importance of distributed manufacturing. #JPM24 #nuclearmedicine

5 Things to Know - Thing 1) Shockwave Medical $SWAV Being Acquired by Johnson & Johnson $JNJ: DKI Takeaway: DKI recommended Shockwave Medical $SWAV to subscribers in December at $190. Our positive thesis was based on an expected takeover for more than $300 per share. Boston Scientific $BSX approached Shockwave last year. They could return to bid again, but given that the $JNJ talks have been public for more than a week and that there’s now a breakup fee, it’s possible but unlikely they re-enter the situation. DKI subscribers made more than 70% in under four months. This is the second DKI portfolio company to be acquired following Houghton Mifflin which was bought for more than 4x DKI’s initial purchase price. If that’s of interest to you, you’re welcome to subscribe. Otherwise, we’ll be happy to keep informing you after the fact. https://lnkd.in/eZBfFWkW

Informative summary in growing field of radiopharmaceuticals.

A very interesting piece of information to follow!